Lab Information

Todd Lee (MD)

Scientist
Clinical Research Unit
Department of Medicine (McGill)

Research Profile

 Fundamental: 30%
 Clinical: 40%
 Epidemiology: 0%
 Evaluation: 30%
 This email address is being protected from spambots. You need JavaScript enabled to view it.
 https://www.drtoddlee.com/

Keywords

Quality improvement • patient safety • high value healthcare • antibiotic stewardship • polypharmacy

Research Interests

My research focuses on conducting randomized clinical trials designed to improve the treatment of infectious diseases (e.g., C. difficile, COVID-19, S. aureus, Gram-Negative infections) and to innovate in the domains of care of complex hospitalized patients, care of older adults with polypharmacy, and stewardship of healthcare resources (e.g., testing, medications).


Team Members

Name Position

Latest Publications

  1. Rocheleau, G. L. Y., Lee, T., Mohammed, Y., Goodlett, D., Burns, K., Cheng, M. P., Tran, K., Sweet, D., Marshall, J., Slutsky, A. S., Murthy, S., Singer, J., Patrick, D. M., Du, B., Peng, Z., Lee, T. C., Boyd, J. H., Walley, K. R., Lamontagne, F., Fowler, R., Winston, B. W., Haljan, G., Vinh, D. C., McGeer, A., Maslove, D., Patrigeon, S. P., Mann, P., Donohoe, K., Hernandez, G., Russell, J. A. & for ARBs CORONA I Investigators (2022). Renin-Angiotensin System Pathway Therapeutics Associated With Improved Outcomes in Males Hospitalized With COVID-19. Critical care medicine.
  2. Lee, T. C., Murthy, S., Del Corpo, O., Senécal, J., Butler-Laporte, G., Sohani, Z. N., Brophy, J. M. & McDonald, E. G. (2022). Remdesivir for the treatment of COVID-19: A systematic review and meta-analysis. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
  3. Moryousef, J., Bortolussi-Courval, É., Podymow, T., Lee, T. C., Trinh, E. & McDonald, E. G. (2022). Deprescribing Opportunities for Hospitalized Patients With End-Stage Kidney Disease on Hemodialysis: A Secondary Analysis of the MedSafer Cluster Randomized Controlled Trial. Canadian journal of kidney health and disease, vol. 9, p. 20543581221098778.
  4. Spellberg, B., Aggrey, G., Brennan, M. B., Footer, B., Forrest, G., Hamilton, F., Minejima, E., Moore, J., Ahn, J., Angarone, M., Centor, R. M., Cherabuddi, K., Curran, J., Davar, K., Davis, J., Dong, M. Q., Ghanem, B., Hutcheon, D., Jent, P., Kang, M., Lee, R., McDonald, E. G., Morris, A. M., Reece, R., Schwartz, I. S., So, M., Tong, S., Tucker, C., Wald-Dickler, N., Weinstein, E. J., Williams, R., Yen, C., Zhou, S., Lee, T. C. & WikiGuidelines Group (2022). Use of Novel Strategies to Develop Guidelines for Management of Pyogenic Osteomyelitis in Adults: A WikiGuidelines Group Consensus Statement. JAMA network open, vol. 5, p. e2211321.
  5. Schwartz, I. S., Boulware, D. R. & Lee, T. C. (2022). Hydroxychloroquine for COVID19: The curtains close on a comedy of errors. Lancet Regional Health. Americas, vol. 11, p. 100268.
  6. Lee, T. C., Morris, A. M., Schwartz, I. S. & McDonald, E. G. (2022). Allocated but not treated: the silent 16. Lancet (London, England), vol. 399, p. 1775.
  7. Lee, T., Cheng, M. P., Vinh, D. C., Lee, T. C., Tran, K. C., Winston, B. W., Sweet, D., Boyd, J. H., Walley, K. R., Haljan, G., McGeer, A., Lamontagne, F., Fowler, R., Maslove, D., Singer, J., Patrick, D. M., Marshall, J. C., Burns, K. D., Murthy, S., Mann, P. K., Hernandez, G., Donohoe, K., Rocheleau, G., Russell, J. A. & ARBs CORONA I study investigators (2022). Organ dysfunction and death in patients admitted to hospital with COVID-19 in pandemic waves 1 to 3 in British Columbia, Ontario and Quebec, Canada: a cohort study. CMAJ open, vol. 10, p. E379-E389.
  8. Bai, A. D., Lo, C. K. L., Komorowski, A. S., Suresh, M., Guo, K., Garg, A., Tandon, P., Senecal, J., Del Corpo, O., Stefanova, I., Fogarty, C., Butler-Laporte, G., McDonald, E. G., Cheng, M. P., Morris, A. M., Loeb, M. & Lee, T. C. (2022). What Is the Optimal Follow-up Length for Mortality in Staphylococcus aureus Bacteremia? Observations From a Systematic Review of Attributable Mortality. Open forum infectious diseases, vol. 9, p. ofac096.
  9. Lee, T. C., Vigod, S., Bortolussi-Courval, É., Hanula, R., Boulware, D. R., Lenze, E. J., Reiersen, A. M. & McDonald, E. G. (2022). Fluvoxamine for Outpatient Management of COVID-19 to Prevent Hospitalization: A Systematic Review and Meta-analysis. JAMA network open, vol. 5, p. e226269.
  10. Bai, A. D., Lo, C. K., Komorowski, A. S., Suresh, M., Guo, K., Garg, A., Tandon, P., Senecal, J., Del Corpo, O., Stefanova, I., Fogarty, C., Butler-Laporte, G., McDonald, E. G., Cheng, M. P., Morris, A. M., Loeb, M. & Lee, T. C. (2022). Staphylococcus aureus bacteremia mortality: A systematic review and meta-analysis. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
More on PubMed 



See also

Card image
Emily
McDonald


See profile
Card image
Matthew
Cheng


See profile
Card image
Donald
Vinh


See profile
Card image
Cédric
Yansouni


See profile
Card image
Donald
Sheppard


See profile
Card image
Nandini
Dendukuri


See profile